Literature DB >> 21320446

Enhanced active cross-bridges during diastole: molecular pathogenesis of tropomyosin's HCM mutations.

Fan Bai1, Adam Weis, Aya K Takeda, P Bryant Chase, Masataka Kawai.   

Abstract

Three HCM-causing tropomyosin (Tm) mutants (V95A, D175N, and E180G) were examined using the thin-filament extraction and reconstitution technique. The effects of Ca(2+), ATP, phosphate, and ADP concentrations on cross-bridge kinetics in myocardium reconstituted with each of these mutants were studied at 25°C, and compared to wild-type (WT) Tm at physiological ionic strength (200 mM). All three mutants showed significantly higher (2-3.5 fold) low Ca(2+) tension (T(LC)) and stiffness than WT at pCa 8.0. High Ca(2+) tension (T(HC)) was significantly higher for E180G than that for WT, whereas T(HC) of V95A and D175N was similar to WT; high Ca(2+) stiffness (Y(HC)) had the same trend. The Ca(2+) sensitivity of isometric force was significantly greater for V95A and E180G than for WT, whereas that of D175N remained the same as for WT; for all mutants, cooperativity was lower than for WT. Nine kinetic constants and the cross-bridge distribution were deduced using sinusoidal analysis. The number of force-generating cross bridges was similar among the D175N, E180G, and WT Tm forms, but it was significantly larger in the case of V95A than WT. We conclude that the increased number of actively cycling cross bridges at pCa 8 is the major cause of Tm mutation-related HCM pathogenesis, which may result in diastolic dysfunction. Decreased contractility (T(act)) in V95A and D175N may further contribute to the severity of myocyte hypertrophy and related prognosis of the disease.
Copyright © 2011 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21320446      PMCID: PMC3037557          DOI: 10.1016/j.bpj.2011.01.001

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  73 in total

1.  Tropomyosin coiled-coil interactions: evidence for an unstaggered structure.

Authors:  A D McLachlan; M Stewart
Journal:  J Mol Biol       Date:  1975-10-25       Impact factor: 5.469

2.  The calcium and magnesium binding sites on cardiac troponin and their role in the regulation of myofibrillar adenosine triphosphatase.

Authors:  M J Holroyde; S P Robertson; J D Johnson; R J Solaro; J D Potter
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

3.  Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy.

Authors:  C C Evans; J R Pena; R M Phillips; M Muthuchamy; D F Wieczorek; R J Solaro; B M Wolska
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-11       Impact factor: 4.733

4.  The effect of partial extraction of troponin C on the elementary steps of the cross-bridge cycle in rabbit psoas muscle fibers.

Authors:  Y Zhao; P M Swamy; K A Humphries; M Kawai
Journal:  Biophys J       Date:  1996-11       Impact factor: 4.033

5.  Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade.

Authors:  Daniel E Michele; Carlen A Gomez; Katie E Hong; Margaret V Westfall; Joseph M Metzger
Journal:  Circ Res       Date:  2002-08-09       Impact factor: 17.367

6.  The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils.

Authors:  Alexandra Belus; Nicoletta Piroddi; Beatrice Scellini; Chiara Tesi; Giulia D'Amati; Francesca Girolami; Magdi Yacoub; Franco Cecchi; Iacopo Olivotto; Corrado Poggesi
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

7.  Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium.

Authors:  Bradley M Palmer; David E Fishbaugher; Joachim P Schmitt; Yuan Wang; Norman R Alpert; Christine E Seidman; J G Seidman; Peter VanBuren; David W Maughan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-03-04       Impact factor: 4.733

Review 8.  Ca(2+) exchange with troponin C and cardiac muscle dynamics.

Authors:  Jonathan P Davis; Svetlana B Tikunova
Journal:  Cardiovasc Res       Date:  2007-12-12       Impact factor: 10.787

Review 9.  Hypertrophic cardiomyopathy.

Authors:  Perry Elliott; William J McKenna
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

10.  Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes.

Authors:  A J Marian; Q T Yu; D L Mann; F L Graham; R Roberts
Journal:  Circ Res       Date:  1995-07       Impact factor: 17.367

View more
  42 in total

Review 1.  The 3-state model of muscle regulation revisited: is a fourth state involved?

Authors:  Sherwin S Lehrer
Journal:  J Muscle Res Cell Motil       Date:  2011-09-25       Impact factor: 2.698

Review 2.  Multi-scale computational models of familial hypertrophic cardiomyopathy: genotype to phenotype.

Authors:  Stuart G Campbell; Andrew D McCulloch
Journal:  J R Soc Interface       Date:  2011-08-10       Impact factor: 4.118

3.  Slowed Dynamics of Thin Filament Regulatory Units Reduces Ca2+-Sensitivity of Cardiac Biomechanical Function.

Authors:  Campion K P Loong; Aya K Takeda; Myriam A Badr; Jordan S Rogers; P Bryant Chase
Journal:  Cell Mol Bioeng       Date:  2013-06-01       Impact factor: 2.321

Review 4.  Nuclear tropomyosin and troponin in striated muscle: new roles in a new locale?

Authors:  P Bryant Chase; Mark P Szczypinski; Elliott P Soto
Journal:  J Muscle Res Cell Motil       Date:  2013-08-02       Impact factor: 2.698

5.  The functional significance of the last 5 residues of the C-terminus of cardiac troponin I.

Authors:  Jennifer E Gilda; Qian Xu; Margaret E Martinez; Susan T Nguyen; P Bryant Chase; Aldrin V Gomes
Journal:  Arch Biochem Biophys       Date:  2016-02-23       Impact factor: 4.013

6.  Structural and functional aspects of the myosin essential light chain in cardiac muscle contraction.

Authors:  Priya Muthu; Li Wang; Chen-Ching Yuan; Katarzyna Kazmierczak; Wenrui Huang; Olga M Hernandez; Masataka Kawai; Thomas C Irving; Danuta Szczesna-Cordary
Journal:  FASEB J       Date:  2011-09-01       Impact factor: 5.191

Review 7.  Interpreting genetic effects through models of cardiac electromechanics.

Authors:  S A Niederer; S Land; S W Omholt; N P Smith
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-10-05       Impact factor: 4.733

8.  Phosphorylation of cMyBP-C affects contractile mechanisms in a site-specific manner.

Authors:  Li Wang; Xiang Ji; David Barefield; Sakthivel Sadayappan; Masakata Kawai
Journal:  Biophys J       Date:  2014-03-04       Impact factor: 4.033

9.  Using baculovirus/insect cell expressed recombinant actin to study the molecular pathogenesis of HCM caused by actin mutation A331P.

Authors:  Fan Bai; Hannah M Caster; Peter A Rubenstein; John F Dawson; Masataka Kawai
Journal:  J Mol Cell Cardiol       Date:  2014-04-30       Impact factor: 5.000

Review 10.  The myosin-activated thin filament regulatory state, M⁻-open: a link to hypertrophic cardiomyopathy (HCM).

Authors:  Sherwin S Lehrer; Michael A Geeves
Journal:  J Muscle Res Cell Motil       Date:  2014-04-17       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.